An EORTC phase II study of methyl-glyoxal bis-guanylhydrazone in advanced renal cell cancer
- 1 January 1982
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 18 (1), 85-87
- https://doi.org/10.1016/0277-5379(82)90030-x
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- PHASE-II TRIAL OF METHYL-GAG IN ADVANCED RENAL-CANCER1981
- CORRELATION OF ULTRASTRUCTURAL AND FUNCTIONAL DAMAGE TO MITOCHONDRIA OF ASCITES L1210 CELLS TREATED INVIVO WITH METHYLGLYOXAL-BIS(GUANYLHYDRAZONE) OR ETHIDIUM-BROMIDE1979
- GENERALITY OF METHYLGLYOXAL BIS-(GUANYLHYDRAZONE)-INDUCED MITOCHONDRIAL DAMAGE AND THE DEPENDENCE OF THIS EFFECT ON CELL-PROLIFERATION1979
- PROGESTOGENS IN RENAL-CELL CARCINOMA - RETROSPECTIVE STUDY1979
- Progestogens in Renal Cell CarcinomaEuropean Urology, 1979
- Current status of the therapy of advanced renal carcinomaJournal of Surgical Oncology, 1977
- Treatment of acute leukemia with methylglyoxal‐bis‐guanylhydrazone (methyl GAG)Clinical Pharmacology & Therapeutics, 1965